The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting temperature’s immune effects.
Year End results as of December 31, 2023 – Biotech Investments
Vitruvia Medical AG / Key word(s): Annual Results/Annual Report Vitruvia Medical AG: Year End results as of December 31, 2023 01-May-2024 / 08:36 CET/CEST Disclosure